Paper · 39757641
Protein Misfolding and Aggregation of Pathological IgG Light Chains in Oncohematological Dyscrasias: From Molecular Pathways to Clinical Implications.
Guman T and 3 others. Curr Protein Pept Sci, 2025. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Protein Misfolding and Aggregation of Pathological IgG Light Chains in Oncohematological Dyscrasias: From Molecular Pathways to Clinical Implications. Papers, record 39757641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39757641
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protein Misfolding and Aggregation of Pathological IgG Light Chains in Oncohematological Dyscrasias: From Molecular Pathways to Clinical Implications.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Folding | Major topic |
| Immunoglobulin Light Chains | Major topic |
| Paraproteinemias | Major topic |
| Immunoglobulin G | Major topic |
| Protein Aggregation, Pathological | Major topic |
| Humans | |
| Animals | |
| B-Lymphocytes |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| APVV-18-0285, APVV-23-0212 | APVV | PubMed | ||
| VEGA 1/0024/22 | VEGA | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References59
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12,358,904 | Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits ('aggregoma'): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses. | Br J Haematol | 2002 | https://conductscience.org/library/papers/12358904 | PubMed |
| 2 | 9,048,542 | Refined structure of an intact IgG2a monoclonal antibody. | Biochemistry | 1997 | https://conductscience.org/library/papers/9048542 | PubMed |
| 3 | 30,971,495 | Stabilization of amyloidogenic immunoglobulin light chains by small molecules. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/30971495 | PubMed |
| 4 | 33,030,218 | A kinetic coupling between protein unfolding and aggregation controls time-dependent solubility of the human myeloma antibody light chain. | Protein Sci | 2020 | https://conductscience.org/library/papers/33030218 | PubMed |
| 5 | 36,401,959 | Aggregation mechanism and branched 3D morphologies of pathological human light chain proteins under reducing conditions. | Colloids Surf B Biointerfaces | 2023 | https://conductscience.org/library/papers/36401959 | PubMed |
| 6 | 11,266,462 | Hsp70 and antifibrillogenic peptides promote degradation and inhibit intracellular aggregation of amyloidogenic light chains. | J Cell Biol | 2001 | https://conductscience.org/library/papers/11266462 | PubMed |
| 7 | 7,838,842 | IgG heavy-chain deposition disease. | Mod Pathol | 1994 | https://conductscience.org/library/papers/7838842 | PubMed |
| 8 | 8,191,615 | Immunoglobulin light chains and the kidney: an overview. | Ultrastruct Pathol | 1994 | https://conductscience.org/library/papers/8191615 | PubMed |
| 9 | 6,156,005 | Structural mutations in a mouse immunoglobulin light chain resulting in failure to be secreted. | Cell | 1980 | https://conductscience.org/library/papers/6156005 | PubMed |
| 10 | 115,698 | Mutations affecting immunoglobulin light chain secretion by myeloma cells. I. Functional analysis by cell fusion. | Eur J Immunol | 1979 | https://conductscience.org/library/papers/115698 | PubMed |
1 to 10 of 59
See all 59 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40,708,522 | Protein Folding, Aggregation, and Liquid-Liquid Phase Separation. | Curr Protein Pept Sci | 2025 | https://conductscience.org/library/papers/40708522 |
Source PubMed
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39757641
GET https://conductscience.org/api/papers/v1/39757641/references?page=2